Pancreas Volume Predicts Progression to Stage 3 Type 1 Diabetes
By Elana Gotkine HealthDay Reporter
THURSDAY, Feb. 15, 2024 -- Measures of pancreas volume and metabolism can predict progression to stage 3 type 1 diabetes, according to a study published online Dec. 27 in Diabetes Care.
John Virostko, Ph.D., from the University of Texas at Austin, and colleagues conducted a multicenter prospective cohort study to compare pancreas volume as assessed by magnetic resonance imaging, metabolic scores derived from oral glucose tolerance testing (OGTT), and a combination of pancreas volume and metabolic scores for predicting progression to stage 3 type 1 diabetes in 65 multiple diabetes-related, autoantibody-positive participants. The pancreas volume index (PVI), OGTT-derived Index60 score, Diabetes Prevention Trial-Type 1 Risk Score (DPTRS), and a combination of PVI and DPTRS were used to assess progression to stage 3 type 1 diabetes.
The researchers found that in the 11 individuals who subsequently experienced progression to stage 3 type 1 diabetes, the PVI, Index60, and DPTRS were all significantly different at study entry compared with the 54 participants who did not experience progression. Across individual study participants, there was no correlation for PVI with metabolic testing. In the 11 individuals diagnosed with stage 3 type 1 diabetes, PVI declined longitudinally, while Index60 and DPTRS increased. For predicting progression to stage 3 from measurements at study entry, the area under the receiver operating characteristic curve was 0.76 for PVI, 0.79 for Index60, 0.79 for DPTRS, and 0.91 for PVI plus DPTRS.
"Pancreas imaging may be useful for informing clinical trials aimed at type 1 diabetes prevention," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
![](/img/logo/vendor/healthday-logo.png)
© 2024 HealthDay. All rights reserved.
Posted February 2024
Read this next
American Diabetes Association, June 21-24
The annual meeting of the American Diabetes Association was held this year from June 21 to 24 in Orlando, Florida, drawing more than 15,000 participants from around the world...
ADA: Inhaled Insulin Shows Promise for Adults With Type 1 Diabetes
THURSDAY, June 27, 2024 -- Inhaled insulin is associated with improved hemoglobin A1c (HbA1c) levels over 16 weeks among adults with type 1 diabetes when compared to usual care...
1990 to 2019 Saw Increase in Life Expectancy in Seniors With T1DM
FRIDAY, June 14, 2024 -- From 1990 to 2019, there was an increase in life expectancy in older people with type 1 diabetes mellitus (T1DM), according to a study published online...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.